Data center REITs drove the S&P 500 real estate sector (XLRE) lower this week amid the rise of the Chinese AI startup ...

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the "drill, baby, drill" slogan in his inaugural address. Earlier this week, Sean Duffy, the newly ...

AbbVie Q4 earnings beat estimates, driven by strong sales of Skyrizi and Rinvoq, with an updated 2027 combined revenue ...

Barclays lowered the firm’s price target on XPLR Infrastructure (NEP) to $7 from $17 and keeps an Underweight rating on the shares. The firm ...

Capital market regulator Sebi rejected the competing open offer made by the US-based entity Danny Gaekwad Developments & ...

NextEra's stock fell 4.5% to close at $70.54 after XPLR, which is majority owned by NextEra Energy and designed to acquire clean-energy projects for the company, hit a record-low stock price, ending ...

Capital market regulator Sebi on Tuesday rejected the competing open offer made by the US-based entity Danny Gaekwad ...

Sebi rejected a competing open offer by Danny Gaekwad Developments & Investments to acquire Religare Enterprises Ltd (REL) ...

Danny Gaekwad plans to launch a competing offer for Religare Enterprises Ltd, challenging the Burman Group's open offer.